Signs and Symptoms, Digestive Clinical Trial
Official title:
Fiber Tolerability In Children Aged 3-7 Year
Determination of the digestive tolerability of the PROMITOR® in children from 3 to 7 years old.
The aim of the trial is to determine, using a dose escalation design, the digestive
tolerability of the PROMITOR®given at the doses of 6, then 9 and finally 12 g (corresponding
to 4, 6, and 8 g of fibers respectively) twice a day with the meals of the morning and of
the evening versus control (maltodextrin, no fiber) over one week of intake in children from
3 to 7 years old.
As it is an exploratory study there is no categorization between primary and secondary
objectives.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02530762 -
Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary Fiber
|
N/A | |
| Completed |
NCT02532985 -
Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary Fiber
|
N/A | |
| Recruiting |
NCT01464814 -
Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules
|
N/A | |
| Completed |
NCT02180035 -
Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDS
|
N/A | |
| Completed |
NCT05603403 -
Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms
|
Phase 4 | |
| Recruiting |
NCT02928484 -
Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function
|
Phase 1/Phase 2 | |
| Completed |
NCT02519374 -
Fiber Tolerability in Children
|
N/A | |
| Completed |
NCT00822328 -
Fermented Milk Drink on Human Intestinal Microflora
|
Phase 2 | |
| Completed |
NCT02253628 -
The Acute Effect of Coffee Consumption on Stomach, Self-reported Gastrointestinal Symptoms and Stress.
|
N/A | |
| Completed |
NCT00251992 -
Nexium Dyspepsia/AST
|
Phase 3 | |
| Completed |
NCT00251914 -
Nexium Dyspepsia/AST
|
Phase 3 | |
| Completed |
NCT01431482 -
Evaluation of the Composition of Human Milk and Health Outcomes in Children
|
||
| Terminated |
NCT01675960 -
Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children
|
Phase 2 | |
| Completed |
NCT00652834 -
Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
|
Phase 4 | |
| Active, not recruiting |
NCT00110708 -
Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
|
Phase 2 |